The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2016
Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation.
СтатьяОбзорConsensus StatementНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Levine Deborah J, Glanville Allan R, Aboyoun Christina, Belperio John, Benden Christian, Berry Gerald J, Hachem Ramsey, Hayes Don, Neil Desley, Reinsmoen Nancy L, Snyder Laurie D, Sweet Stuart, Tyan Dolly, Verleden Geert, Westall Glen, Yusen Roger D, Zamora Martin, Zeevi Adriana
Аннотация
Antibody-mediated rejection (AMR) is a recognized cause of allograft dysfunction in lung transplant recipients. Unlike AMR in other solid-organ transplant recipients, there are no standardized diagnostic criteria or an agreed-upon definition. Hence, a working group was created by the International Society for Heart and Lung Transplantation with the aim of determining criteria for pulmonary AMR and establishing a definition. Diagnostic criteria and a working consensus definition were established. Key diagnostic criteria include the presence of antibodies directed toward donor human leukocyte antigens and characteristic lung histology with or without evidence of complement 4d within the graft. Exclusion of other causes of allograft dysfunction increases confidence in the diagnosis but is not essential. Pulmonary AMR may be clinical (allograft dysfunction which can be asymptomatic) or sub-clinical (normal allograft function). This consensus definition will have clinical, therapeutic and research implications.